Article thumbnail

Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial

By Arnaud Pigneux, Christian Récher, Marie C. Bene, Julien Asselineau, Ariane C. Mineur, Thibaut Leguay, Jacques Delaunay, Caroline Bonmati, Romain Guièze, Isabelle Luquet, Pascale Cornillet-Lefebvre, Catherine Lacombe, Jean-Christophe Ianotto, Mario Ojeda, Mathilde Hunault, Anne Banos, Bruno Lioure, Marc Bernard, Eric Jourdan, Norbert Vey, Hacène Zerazhi, Hichri Yosr, Roselyne Delépine, Rachid Salmi, François Dreyfus, Jean-Yves Cahn and Norbert Ifrah


International audienceno abstrac

Topics: [SDV]Life Sciences [q-bio]
Publisher: 'American Society of Hematology'
Year: 2015
OAI identifier: oai:HAL:hal-01295674v1
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.